IX001 TCR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IX001 TCR-T, covering 2024-07-05 to 2024-07-05. Get the full timeline:
Most recent: Clinical Trial Update: IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations [Phase 1]